Search

Your search keyword '"Ruijter, Bastian N."' showing total 14 results
Start Over Author "Ruijter, Bastian N."
14 results on '"Ruijter, Bastian N."'

1. Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial)

Author

Hendriks, Pim, Rietbergen, Daphne D. D., van Erkel, Arian R., Coenraad, Minneke J., Arntz, Mark J., Bennink, Roel J., Braat, Andries E., Crobach, Stijn, van Delden, Otto M., Dibbets-Schneider, Petra, van der Hulle, Tom, Klümpen, Heinz-Josef, van der Meer, Rutger W., Nijsen, J. Frank W., van Rijswijk, Catharina S. P., Roosen, Joey, Ruijter, Bastian N., Smit, Frits, Stam, Mette K., Takkenberg, R. Bart, Tushuizen, Maarten E., van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, and Burgmans, Mark C.

Published
2024
Full Text
View/download PDF

3. Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)

Author

Hendriks, Pim, Rietbergen, Daphne D. D., van Erkel, Arian R., Coenraad, Minneke J., Arntz, Mark J., Bennink, Roel J., Braat, Andries E., Crobach, A. Stijn L. P., van Delden, Otto M., van der Hulle, Tom, Klümpen, Heinz-Josef, van der Meer, Rutger W., Nijsen, J. Frank W., van Rijswijk, Carla S. P., Roosen, Joey, Ruijter, Bastian N., Smit, Frits, Stam, Mette K., Takkenberg, R. Bart, Tushuizen, Maarten E., van Velden, Floris H. P., de Geus-Oei, Lioe-Fee, and Burgmans, Mark C.

Published
2022
Full Text
View/download PDF

5. Primary sclerosing cholangitis and other risk factors for post-transplant lymphoproliferative disease after liver transplantation in adults

Author

Ruijter, Bastian N., primary, Tushuizen, Maarten E., additional, van der Helm, Danny, additional, Hew, Mitchel, additional, Reeven, Marjolein, additional, Vossen, Ann C.T.M., additional, Metselaar, Herold J., additional, Alwayn, Ian P.J., additional, Dubbeld, Jeroen, additional, Polak, Wojciech G., additional, and van Hoek, Bart, additional

Published
2023
Full Text
View/download PDF

6. Use of very short answer questions compared to multiple choice questions in undergraduate medical students: An external validation study

Author

van Wijk, Elise V., primary, Janse, Roemer J., additional, Ruijter, Bastian N., additional, Rohling, Jos H. T., additional, van der Kraan, Jolein, additional, Crobach, Stijn, additional, Jonge, Mario de, additional, Beaufort, Arnout Jan de, additional, Dekker, Friedo W., additional, and Langers, Alexandra M. J., additional

Published
2023
Full Text
View/download PDF

7. Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation:DELTA Study

Author

Ruijter, Bastian N., Inderson, Akin, van den Berg, Aad P., Metselaar, Herold J., Dubbeld, Jeroen, Tushuizen, Maarten E., Porte, Robert J., Polak, Wojciech, van der Helm, Danny, van Reeven, Marjolein, Rodriguez-Girondo, Mar, van Hoek, Bart, Ruijter, Bastian N., Inderson, Akin, van den Berg, Aad P., Metselaar, Herold J., Dubbeld, Jeroen, Tushuizen, Maarten E., Porte, Robert J., Polak, Wojciech, van der Helm, Danny, van Reeven, Marjolein, Rodriguez-Girondo, Mar, and van Hoek, Bart

Abstract

Background and Aims: Previous trials comparing cyclosporine and tacrolimus after liver transplantation (LT) showed conflicting results. Most used trough monitoring for cyclosporine (C0), leading to less accurate dosing than with 2-h monitoring (C2). Only one larger trial compared C2 with tacrolimus based on trough level (T0) after LT, with similar treated biopsy-proven acute rejection (tBPAR) and graft loss, while a smaller trial had less tBPAR with C2 compared to T0. Therefore, it is still unclear which calcineurin inhibitor is preferred after LT. We aimed to demonstrate superior efficacy (tBPAR), tolerability, and safety of C2 or T0 after first LT. Methods: Patients after first LT were randomized to C2 or T0. tBPAR, patient-and graft survival, safety and tolerability were the main endpoints, with analysis by Fisher test, Kaplan–Meier survival analysis and log-rank test. Results: In intention-to treat analysis 84 patients on C2 and 85 on T0 were included. Cumulative incidence of tBPAR C2 vs. T0 was 17.7% vs. 8.4% at 3 months (p=0.104), and 21.9% vs. 9.7% at 6 and 12 months (p=0.049). One-year cumulative mortality C2 vs. T0 was 15.5% vs. 5.9% (p=0.049) and graft loss 23.8% vs. 9.4% (p=0.015). Serum triglyceride and LDL-cholesterol was lower with T0 than with C2. Incidence of diarrhea in T0 vs, C2 was 64% vs. 31% (p≤0.001), with no other differences in safety and tolerability. Conclusions: In the first year after LT immunosuppression with T0 leads to less tBPAR and better patient-/re-transplant-free survival as compared to C2.

Published
2023

8. Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study

Author

Ruijter, Bastian N., primary, Inderson, Akin, additional, van den Berg, Aad P., additional, Metselaar, Herold J., additional, Dubbeld, Jeroen, additional, Tushuizen, Maarten E., additional, Porte, Robert J., additional, Polak, Wojciech, additional, van der Helm, Danny, additional, van Reeven, Marjolein, additional, Rodriguez-Girondo, Mar, additional, and van Hoek, Bart, additional

Published
2023
Full Text
View/download PDF

9. Epstein–Barr Viral Load Monitoring Strategy and the Risk for Posttransplant Lymphoproliferative Disease in Adult Liver Transplantation

Author

Ruijter, Bastian N., primary, Wolterbeek, Ron, additional, Hew, Mitchell, additional, van Reeven, Marjolein, additional, van der Helm, Danny, additional, Dubbeld, Jeroen, additional, Tushuizen, Maarten E., additional, Metselaar, Herold, additional, Vossen, Ann C.T.M., additional, and van Hoek, Bart, additional

Published
2023
Full Text
View/download PDF

11. Comparison of Very Short Answer Questions and Multiple Choice Questions in Medical Students: Reliability, Discrimination, Acceptability and Effect on Knowledge Retention

Author

Janse, Roemer J., primary, van Wijk, Elise V., additional, Ruijter, Bastian N., additional, Rohling, Jos H.T., additional, van der Kraan, Jolein, additional, Crobach, A. Stijn L.P., additional, de Jonge, Mario, additional, Beaufort, Arnout Jan de, additional, Dekker, Friedo W., additional, and Langers, Alexandra M.J., additional

Published
2022
Full Text
View/download PDF

12. Grand Round: Case report of the broad spectrum of late complications in an adult patient with univentricular physiology palliated by the Fontan circulation

Author

Nederend, Marieke, primary, Egorova, Anastasia D, additional, Vliegen, Hubert W, additional, Roest, Arno A W, additional, Ruijter, Bastian N, additional, Korteweg, Tijmen, additional, Ninaber, Maarten K, additional, Zeppenfeld, Katja, additional, Hazekamp, Mark G, additional, Kiès, Philippine, additional, and Jongbloed, Monique R M, additional

Published
2022
Full Text
View/download PDF

14. Case report of the broad spectrum of late complications in an adult patient with univentricular physiology palliated by the Fontan circulation.

Author

Nederend, Marieke, Egorova, Anastasia D, Vliegen, Hubert W, Roest, Arno A W, Ruijter, Bastian N, Korteweg, Tijmen, Ninaber, Maarten K, Zeppenfeld, Katja, Hazekamp, Mark G, Kiès, Philippine, and Jongbloed, Monique R M

Subjects
CONGENITAL heart disease, VENA cava inferior, VENA cava superior, PULMONARY circulation, CARDIAC patients, TRANSPOSITION of great vessels
Abstract

Background At the most severe end of the spectrum of congenital heart disease are patients with an univentricular physiology. They comprise a heterogeneous group of congenital heart malformations that have the common characteristic that the cardiac morphology is not equipped for sustaining a biventricular circulation. Case summary Here, we present a case of an adult patient after Fontan palliation, illustrative of the complex clinical course and the broad spectrum of complications that can be encountered during follow-up, highlighting the need for a multidisciplinary approach in the clinical care for these patients. Discussion During the surgical Fontan procedure, the inferior vena cava is connected to the pulmonary circulation, after prior connection of the superior vena cava to the pulmonary arterial circulation. The resulting cavopulmonary connection, thus lacking a subpulmonic ventricle, provides non-pulsatile passive flow of oxygen-poor blood from the systemic venous circulation into the lungs, and the functional monoventricle pumps the oxygen-rich pulmonary venous return blood into the aorta. With an operative mortality of <5% and current 30-year survival rates up to 85%, the adult population of patients with a Fontan circulation is growing. This increase in survival is, however, inevitably accompanied by long-term complications affecting multiple organ systems, resulting in decline in cardiovascular performance. Conclusion For optimal treatment, the evaluation in a multidisciplinary team is mandatory, using the specific expertise of the team members to timely detect and address late complications and to support quality of life. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results